Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18539,153,1.12 [0.93-1.34],0.2259242404896293
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19487,201,1.00 [0.84-1.19],0.9979131921945076
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19265,1408,1.00 [0.93-1.07],0.9974448157697609
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19504,446,1.10 [0.99-1.22],0.085569249075454
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18860,3448,1.00 [0.96-1.05],0.9223559917720018
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18844,3494,1.00 [0.96-1.05],0.9155111090302565
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19259,1150,1.00 [0.93-1.08],0.9895092828608092
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19417,108,0.95 [0.73-1.22],0.6731759031087042
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17206,1018,1.01 [0.93-1.09],0.8681877369812083
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16578,1231,1.01 [0.94-1.08],0.8504901646258138
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16242,269,1.07 [0.92-1.23],0.3823242901711922
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12703,2208,0.99 [0.93-1.04],0.6031733135102254
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16191,393,0.94 [0.82-1.08],0.3769258907930862
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19469,1360,0.99 [0.93-1.06],0.8713593313690187
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Mycoses,19575,517,1.09 [0.99-1.21],0.0756016160574772
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18852,995,1.00 [0.92-1.08],0.9764465312827716
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19516,1130,1.01 [0.93-1.08],0.8730309540443616
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18310,201,1.00 [0.84-1.19],0.9793244311353644
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19624,50,0.92 [0.62-1.35],0.6600715794420033
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19368,982,1.01 [0.93-1.09],0.8268946995426175
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19371,62,0.88 [0.61-1.27],0.4935463648461881
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19567,110,0.97 [0.75-1.24],0.7875597975401493
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19553,96,0.89 [0.67-1.20],0.4488239868807523
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18235,378,0.95 [0.83-1.09],0.4890776225133195
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18107,250,1.04 [0.89-1.21],0.6448134740227378
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18208,99,0.88 [0.66-1.17],0.3711528887243642
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19610,45,0.94 [0.63-1.42],0.7789812778286765
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19564,152,0.82 [0.64-1.05],0.1159391914557917
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Viral warts,19461,49,0.54 [0.30-0.98],0.0425752473696592
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19484,72,0.95 [0.70-1.31],0.7706739623921661
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19378,224,0.75 [0.60-0.94],0.0111019786244758
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19551,37,0.83 [0.51-1.38],0.4780708381074613
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19537,41,0.81 [0.50-1.33],0.4103639618214005
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9282,69,0.78 [0.53-1.15],0.2118897303557458
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19239,1410,1.02 [0.95-1.09],0.5628649151832309
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of meninges,19610,54,0.89 [0.61-1.31],0.5689329406009002
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19543,67,0.91 [0.65-1.28],0.5866472267701772
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19603,92,1.04 [0.81-1.34],0.7365235094229308
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm of ovary,10292,63,1.10 [0.83-1.46],0.4932527859256702
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19589,377,1.07 [0.95-1.21],0.2633394124173999
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Caecum,19603,322,0.97 [0.84-1.12],0.6666541375012578
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19500,74,1.02 [0.76-1.36],0.9009083689813528
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,19588,221,0.98 [0.82-1.17],0.8188007782317441
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Rectum,19546,344,0.97 [0.85-1.12],0.7001901548706143
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19494,591,1.12 [1.02-1.22],0.0156998465720866
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19583,451,1.00 [0.89-1.13],0.948970678909309
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Carcinoma in situ of breast,7742,44,0.96 [0.65-1.42],0.8466412428143171
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7775,54,1.16 [0.87-1.55],0.3037126361968632
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14064,63,0.37 [0.20-0.69],0.0018294560209866
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14083,82,0.99 [0.75-1.30],0.922854341114762
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19572,108,1.06 [0.84-1.32],0.6292543161402955
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Haemangioma, any site",19573,105,1.06 [0.84-1.33],0.6418649124231434
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Leiomyoma of uterus,10056,144,1.11 [0.93-1.34],0.2556975514002637
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Lung cancer and mesothelioma,12515,424,1.08 [0.97-1.21],0.1623622759465282
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Lymphoid leukaemia,14065,64,0.49 [0.28-0.85],0.0112007962384239
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14188,187,1.09 [0.92-1.28],0.3194034897739469
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14258,257,0.97 [0.83-1.14],0.7501986344791922
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7852,92,0.99 [0.76-1.29],0.9548274483483434
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14096,95,1.27 [1.05-1.54],0.0145866294327559
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14121,120,0.92 [0.71-1.18],0.4991040390429773
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14110,109,1.03 [0.82-1.30],0.791524475888606
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7841,81,0.76 [0.53-1.10],0.1420000435086921
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14108,107,0.88 [0.66-1.15],0.3462764771915279
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7040,799,0.89 [0.80-0.99],0.0244355153991966
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14110,109,0.88 [0.67-1.16],0.3618001616694132
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14078,77,1.05 [0.80-1.38],0.7034857120911399
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14119,118,0.95 [0.74-1.21],0.6609739132202787
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanocytic naevi,19500,155,1.04 [0.85-1.26],0.724462208546182
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanocytic naevi of trunk,19600,66,1.14 [0.87-1.48],0.3398620475531894
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Melanoma in situ,14048,97,1.04 [0.82-1.32],0.7260898636666884
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14103,102,0.98 [0.76-1.26],0.8768431130496039
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14167,166,1.06 [0.88-1.27],0.5467546320768326
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14296,295,0.99 [0.86-1.15],0.9378084620755646
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14108,107,1.09 [0.88-1.35],0.4529150006093968
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,Other benign neoplasms of skin,19477,146,0.91 [0.72-1.15],0.4183914361974399
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15250,1249,1.05 [0.98-1.12],0.1790391568822185
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15317,1316,1.04 [0.97-1.11],0.2497963188155111
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19375,319,0.96 [0.83-1.11],0.5810151478103682
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17725,107,1.03 [0.82-1.29],0.8113724600603923
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19117,61,1.29 [1.03-1.63],0.027825678559452
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19027,2872,1.00 [0.95-1.05],0.9256892383259572
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18235,57,1.00 [0.72-1.39],0.9990749361137709
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19242,57,0.82 [0.54-1.23],0.3347253534858772
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19231,1613,0.97 [0.91-1.03],0.3003540525658414
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19229,1611,0.97 [0.91-1.03],0.3084793007110498
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17711,93,0.99 [0.76-1.29],0.960491213268232
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19328,1150,1.02 [0.94-1.09],0.6701486383239518
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19285,100,1.14 [0.92-1.41],0.2213109093865725
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19111,55,1.20 [0.92-1.58],0.1765242899761525
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19124,68,1.18 [0.92-1.52],0.2023814401003694
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19470,285,0.83 [0.70-1.00],0.0458834214296166
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19519,33,1.27 [0.92-1.76],0.1443607156833349
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19419,234,0.81 [0.66-0.99],0.0428712454905125
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18290,112,0.86 [0.65-1.13],0.2809810987092662
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13266,329,0.94 [0.80-1.09],0.4010351446266674
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18367,85,1.07 [0.82-1.40],0.6321299718416342
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18375,93,1.00 [0.77-1.31],0.9849703085659944
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12998,61,1.20 [0.92-1.57],0.1779462543920466
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18272,44,1.00 [0.68-1.47],0.9971913518445488
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17644,260,1.09 [0.94-1.25],0.2404836772018684
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18986,744,0.97 [0.88-1.06],0.4843936269326765
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18644,402,0.97 [0.85-1.10],0.5874693248343528
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18391,149,0.86 [0.68-1.10],0.2330538655173802
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19398,1170,0.96 [0.88-1.03],0.2441847662809881
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16609,1140,0.96 [0.89-1.04],0.313125888407299
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13005,68,0.91 [0.65-1.29],0.6127184785495519
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17741,84,0.92 [0.69-1.24],0.6057029094315067
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13228,291,0.96 [0.82-1.12],0.6167626830516155
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12985,48,0.84 [0.54-1.31],0.4495365761564552
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16770,3833,1.02 [0.98-1.06],0.2863333309762885
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13167,230,1.13 [0.97-1.30],0.1101375238695919
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13522,585,1.01 [0.91-1.12],0.8201475807755061
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19578,300,0.99 [0.85-1.15],0.8886747604223773
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19401,123,1.20 [1.00-1.44],0.046311337240067
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13065,128,0.88 [0.68-1.14],0.3425816019005937
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13006,69,0.87 [0.61-1.24],0.4424597049733821
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19091,1434,1.01 [0.94-1.08],0.8185647903901225
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13242,305,0.89 [0.76-1.06],0.1860813543422515
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13260,323,1.00 [0.87-1.15],0.9719801904935595
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13649,712,1.06 [0.97-1.16],0.1978097943551749
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13063,126,1.00 [0.80-1.25],0.9993949775109788
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19395,117,1.20 [0.99-1.44],0.0567986976690667
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13686,749,0.97 [0.88-1.07],0.5132178357118881
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13482,545,1.06 [0.96-1.17],0.2801017601301741
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17443,59,0.81 [0.53-1.22],0.3057446832485483
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18320,5383,1.02 [0.99-1.06],0.1756047565513
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17706,49,0.90 [0.60-1.35],0.6220652561871374
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17700,43,1.13 [0.81-1.57],0.4784392256480518
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19477,1565,1.00 [0.94-1.07],0.9746974929306476
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19475,1563,1.00 [0.94-1.07],0.9323342685342094
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17712,55,0.56 [0.33-0.98],0.0406252430669799
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19329,960,1.04 [0.96-1.12],0.3346220439562894
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14771,1834,1.00 [0.95-1.07],0.893209243551246
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19614,238,0.89 [0.74-1.07],0.2082109890069371
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18334,92,0.81 [0.59-1.13],0.2107087766673004
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18468,99,0.81 [0.59-1.11],0.1824003249373559
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18512,143,1.02 [0.83-1.26],0.8304667978721162
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13098,161,1.00 [0.82-1.22],0.9925399527757702
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17277,157,0.95 [0.77-1.19],0.6752851087450851
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2095,81,0.71 [0.48-1.03],0.0742032706015734
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2234,253,1.04 [0.90-1.21],0.5808729605752685
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17188,68,1.19 [0.92-1.54],0.1754675630677612
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2063,50,0.62 [0.36-1.06],0.0824802936601032
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18933,1813,0.98 [0.92-1.04],0.4525434069465144
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18737,495,0.97 [0.87-1.09],0.6456305373108424
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17745,361,1.03 [0.91-1.18],0.6024553800060966
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13828,891,1.09 [1.01-1.17],0.0366343989487951
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19510,261,1.12 [0.97-1.28],0.1109827298635706
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18404,224,0.94 [0.78-1.13],0.4880870963271611
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Angina pectoris,17012,1286,0.98 [0.91-1.05],0.5574820370559506
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18491,311,0.94 [0.81-1.10],0.4585212586402484
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18248,68,1.03 [0.76-1.39],0.845694550242875
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18414,234,1.15 [1.00-1.32],0.0544741838367718
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9998,2324,1.01 [0.96-1.06],0.7066468442967522
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,AV-block,15036,547,1.00 [0.89-1.11],0.9444061538957328
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19552,465,0.99 [0.88-1.12],0.900957760252476
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,7890,216,0.87 [0.71-1.07],0.1874770778337293
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14662,173,0.87 [0.70-1.09],0.2251321798701242
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14578,89,0.98 [0.74-1.29],0.8837596354649533
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19618,59,1.01 [0.73-1.39],0.9544313232358024
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Conduction disorders,15760,1271,1.03 [0.96-1.10],0.3945014668817219
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18006,2302,0.98 [0.93-1.03],0.4811456672333554
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15893,7543,0.99 [0.96-1.02],0.4014831990976162
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18324,287,1.12 [0.99-1.28],0.0744064235865771
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Endocarditis,14566,77,1.08 [0.83-1.40],0.5803336279630784
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19381,1366,0.99 [0.93-1.06],0.8535736353477272
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypertension,16935,6681,0.98 [0.95-1.01],0.1745270196637802
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16939,6685,0.98 [0.95-1.01],0.1742325342407999
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19481,85,1.10 [0.86-1.40],0.4410648798365965
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10493,239,0.95 [0.79-1.13],0.5343157909378276
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10378,124,0.93 [0.72-1.19],0.5399646384518324
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Hypotension,19472,1302,0.95 [0.89-1.03],0.2104217854391625
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18567,118,1.17 [0.97-1.42],0.0999973548694354
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18165,2439,0.99 [0.94-1.04],0.6341696755555122
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19210,660,1.10 [1.01-1.20],0.0263786973436458
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14912,423,1.09 [0.97-1.22],0.1393229271200423
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19070,875,0.96 [0.88-1.05],0.4042347197255561
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16481,755,0.95 [0.86-1.04],0.2757758607853222
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19511,163,0.90 [0.73-1.13],0.3713235748588267
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19586,339,0.98 [0.85-1.12],0.7501920842442724
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18094,57,0.85 [0.57-1.26],0.4203109948576218
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other aneurysm,18266,86,1.14 [0.90-1.44],0.2905208478014822
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,14978,489,0.91 [0.81-1.04],0.1689252509814848
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18288,108,0.96 [0.74-1.24],0.7397091056796714
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18445,265,1.11 [0.97-1.28],0.1302095429957744
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14677,188,0.98 [0.81-1.18],0.801533175767967
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,18125,88,0.91 [0.68-1.23],0.5368801396866957
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18075,38,1.17 [0.83-1.66],0.3593001470501488
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17949,72,1.14 [0.88-1.47],0.3308304900510174
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18176,139,1.06 [0.87-1.29],0.5620658928824824
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15667,1178,0.98 [0.91-1.06],0.6678081805612888
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18220,50,0.64 [0.37-1.09],0.1000389701528303
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18774,594,1.07 [0.98-1.18],0.1447645685999969
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18985,452,0.99 [0.88-1.12],0.9258822353392472
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18670,793,1.01 [0.93-1.11],0.8021699088627116
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8013,339,0.97 [0.84-1.12],0.6735734977566079
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18636,486,1.05 [0.95-1.17],0.3364928912386586
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18397,360,1.11 [0.98-1.24],0.0966631077848135
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19026,493,1.04 [0.93-1.16],0.4977954816518114
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19535,795,0.98 [0.89-1.07],0.5993073621464033
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14915,426,1.03 [0.92-1.16],0.6030663068242907
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18980,447,0.98 [0.87-1.11],0.8017720975230548
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18087,210,0.96 [0.80-1.15],0.6755436075635783
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19194,745,1.11 [1.03-1.21],0.0098151504813189
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19181,776,1.10 [1.02-1.20],0.0165134966993735
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18539,48,0.93 [0.62-1.38],0.7041671330112946
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18262,82,1.02 [0.78-1.34],0.8814778560547828
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18804,254,1.11 [0.96-1.28],0.1464182226034951
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18461,266,0.89 [0.75-1.06],0.2052000302506064
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Varicose veins,18463,426,1.09 [0.98-1.22],0.1198583290067928
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18195,99,1.02 [0.80-1.31],0.8628008520228599
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19389,784,1.07 [0.98-1.16],0.1208751097574039
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19556,279,1.06 [0.91-1.22],0.464142088377402
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16865,1165,1.02 [0.95-1.10],0.5813320688874009
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Any mental disorder,19191,3491,1.02 [0.97-1.06],0.4784491787616249
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19533,328,1.08 [0.95-1.23],0.2279908293653976
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16891,1191,0.96 [0.89-1.04],0.3449095600940888
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15763,63,0.86 [0.59-1.25],0.4369639082694375
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Smoking dependency,19188,973,1.03 [0.95-1.12],0.4901932368752951
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16908,1208,1.04 [0.97-1.12],0.2303291174359831
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter V Mental and behavioural disorders,Vascular dementia,18923,194,0.98 [0.82-1.18],0.8416808939276361
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Alzheimer disease,19621,495,1.01 [0.91-1.13],0.8595507962534705
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12230,89,1.10 [0.87-1.39],0.420422815354938
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Bell's palsy,18098,70,1.09 [0.83-1.43],0.5447764109732192
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18443,415,0.92 [0.81-1.06],0.2455252505466134
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Cerebral cysts,19256,198,1.11 [0.95-1.30],0.2072313111113183
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19560,325,1.02 [0.89-1.17],0.7597251231404267
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18937,73,0.83 [0.58-1.18],0.3020585706945827
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19605,60,1.06 [0.78-1.43],0.720016323015011
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19124,66,1.16 [0.89-1.50],0.2643762598956634
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Epilepsy,18387,247,0.92 [0.77-1.09],0.3311011864052701
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19239,1099,0.94 [0.87-1.02],0.1527297713837157
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19573,537,1.04 [0.94-1.15],0.4820121087990253
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19073,2804,1.01 [0.96-1.05],0.7924349521519812
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19318,45,1.15 [0.84-1.58],0.3727722135702386
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Hemiplegia,19501,266,1.01 [0.86-1.17],0.9288898539409868
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Hydrocephalus,19118,60,0.88 [0.61-1.28],0.5167239987470694
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19610,58,0.91 [0.63-1.31],0.6003118678328669
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18088,60,0.94 [0.66-1.33],0.7245214243471474
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18087,59,0.61 [0.36-1.01],0.0540730107329763
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Memory loss,18710,128,0.85 [0.65-1.10],0.2139413031791852
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Migraine,18375,235,0.95 [0.80-1.13],0.5421575207991197
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19579,214,1.00 [0.84-1.19],0.986583633699466
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Motor neuron disease,12327,165,0.89 [0.71-1.11],0.298607131986896
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19515,51,0.72 [0.44-1.17],0.1844251304503828
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19032,1004,0.97 [0.89-1.05],0.4400412783598423
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Neurological diseases,18380,3467,0.99 [0.95-1.03],0.5883144122258037
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19105,241,1.00 [0.85-1.17],0.9955861405614
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18356,328,1.02 [0.89-1.17],0.781478306883491
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19552,285,1.04 [0.90-1.20],0.6112954855043912
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14892,796,0.99 [0.91-1.09],0.8919941465449934
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19125,67,1.02 [0.76-1.38],0.8851226081723359
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19190,132,0.91 [0.72-1.17],0.4681912343952761
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19214,178,0.99 [0.82-1.19],0.8895522785577555
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18105,77,1.08 [0.83-1.41],0.5474703259437939
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other headache syndromes,18184,44,0.64 [0.36-1.12],0.1173795615289365
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other neurological diseases,19527,469,1.02 [0.91-1.14],0.7671816860650724
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Other sleep disorders,18556,416,0.83 [0.71-0.96],0.014239266688838
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Parkinson's disease,19590,339,1.08 [0.96-1.22],0.206384385980256
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19096,38,1.32 [1.00-1.75],0.0540048954322612
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,19620,79,0.90 [0.66-1.23],0.5159646647590292
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19435,359,0.81 [0.69-0.95],0.012037765723741
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19317,50,1.22 [0.93-1.61],0.1532393894254254
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19609,185,0.88 [0.71-1.08],0.2182373474987133
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18087,59,0.71 [0.45-1.12],0.1459751626019236
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19621,500,1.00 [0.90-1.12],0.93021961586634
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18868,188,0.95 [0.79-1.15],0.6172206511099724
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19087,124,0.75 [0.55-1.01],0.0578024814306046
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19257,475,1.03 [0.92-1.15],0.6480334361808795
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19419,222,1.10 [0.94-1.28],0.2297787567561157
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18574,58,1.09 [0.82-1.47],0.5446909367237882
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18551,35,1.29 [0.95-1.75],0.103675759683748
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19520,60,1.13 [0.86-1.49],0.3910957338567268
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19355,191,1.11 [0.94-1.30],0.2219564735166876
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2067,53,0.63 [0.37-1.06],0.0805007282298861
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2542,92,0.75 [0.54-1.05],0.0959127898731299
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19057,94,1.04 [0.81-1.33],0.7512079793325817
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19389,1200,0.99 [0.92-1.06],0.7113416399818289
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19267,751,1.04 [0.95-1.13],0.4297615540904229
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18771,255,1.01 [0.86-1.18],0.9475932115199484
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19567,785,1.03 [0.94-1.12],0.5401791098370889
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19615,67,1.34 [1.08-1.66],0.0081133660340092
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19515,733,1.05 [0.96-1.14],0.3179067638833779
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19587,423,1.00 [0.88-1.13],0.9660698844534524
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19520,186,0.99 [0.82-1.19],0.9194585154788844
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18603,87,0.91 [0.68-1.23],0.5427981551849808
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18603,87,0.71 [0.49-1.04],0.0761217520832954
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18583,67,1.02 [0.76-1.38],0.8912804477422214
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19504,848,1.02 [0.94-1.11],0.5657145356880471
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18883,227,0.88 [0.73-1.07],0.2053367475848488
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18840,58,0.83 [0.56-1.24],0.3640171636090934
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19271,107,0.85 [0.63-1.13],0.2608657663710599
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19493,329,1.06 [0.93-1.20],0.3935637020849108
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18963,181,1.08 [0.91-1.28],0.3918309604274947
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19449,115,1.08 [0.88-1.34],0.4505954070281865
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19210,554,1.01 [0.91-1.13],0.8057556452549077
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19098,135,0.81 [0.62-1.06],0.1291700579938482
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17563,2735,1.01 [0.96-1.06],0.7966166813879801
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19456,292,1.08 [0.95-1.24],0.24112302408599
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19606,156,0.90 [0.72-1.13],0.3499428425935118
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18980,464,1.01 [0.90-1.13],0.9287157199411096
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19245,81,0.91 [0.67-1.24],0.5487719370213744
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19607,59,1.24 [0.96-1.60],0.1062784849796328
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18624,108,1.21 [1.00-1.46],0.0519449368722808
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18669,153,1.02 [0.83-1.24],0.8817377091098024
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18326,137,0.86 [0.67-1.10],0.226535094055531
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18829,47,0.79 [0.50-1.26],0.322168228955897
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18253,64,1.07 [0.80-1.43],0.6646863494802469
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18753,97,1.10 [0.87-1.38],0.4354296116735328
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18902,246,0.95 [0.80-1.13],0.5616167618561987
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18647,131,1.13 [0.93-1.36],0.2211884848340634
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18266,77,1.25 [1.00-1.55],0.0462157868602215
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18292,103,0.99 [0.77-1.27],0.9361367927440962
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17103,2275,0.98 [0.93-1.04],0.5489025475987562
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18594,78,0.87 [0.62-1.21],0.4036487163000808
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19385,422,0.92 [0.81-1.06],0.2421742445896773
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19029,66,1.08 [0.81-1.44],0.6103510733854485
KCNH2,Potassium voltage-gated channel subfamily H member 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19122,159,1.02 [0.84-1.24],0.8324913317887255
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19428,94,0.80 [0.58-1.11],0.1826828561055771
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19586,119,1.02 [0.81-1.28],0.8815985725671229
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19512,94,0.71 [0.50-1.02],0.0659756768373374
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19391,57,0.99 [0.71-1.39],0.975555946313614
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19395,61,0.95 [0.68-1.33],0.7698787164397182
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19529,1004,0.93 [0.85-1.01],0.0763232061603413
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19286,761,0.89 [0.81-0.99],0.0309297348920245
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18648,123,0.93 [0.73-1.19],0.5641283824818121
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18600,75,1.10 [0.85-1.43],0.4537498461036273
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19452,48,1.29 [1.00-1.68],0.0520525256093785
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19555,151,1.26 [1.08-1.47],0.0031690236030508
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19456,52,1.23 [0.94-1.62],0.130491110776341
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,All influenza,17417,126,1.00 [0.80-1.26],0.9662117483860996
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17414,123,1.01 [0.80-1.26],0.9413086209503786
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12176,85,1.10 [0.86-1.41],0.439142494581774
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19540,202,1.03 [0.87-1.22],0.7450547846223035
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13254,1480,1.03 [0.96-1.10],0.4019155072830642
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13553,1462,1.02 [0.96-1.09],0.5024053102149528
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19180,150,1.02 [0.83-1.25],0.8708421977672245
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17376,85,1.02 [0.78-1.34],0.8652139607736719
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Bronchiectasis,16425,432,0.86 [0.74-0.99],0.037113158311172
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16055,62,1.03 [0.76-1.40],0.8433269888143853
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18668,2675,0.99 [0.94-1.04],0.7373464270196017
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18578,65,1.02 [0.75-1.38],0.9202010529800564
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18626,113,0.80 [0.60-1.08],0.1438571568018943
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19375,1352,0.98 [0.92-1.06],0.6568268527228838
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18584,71,0.83 [0.58-1.20],0.3251456966843772
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17798,5101,1.00 [0.96-1.03],0.8582692126116779
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18806,293,0.90 [0.76-1.06],0.1933502048862869
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Early onset COPD,18121,98,1.01 [0.78-1.32],0.915439787132314
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Emphysema,16360,367,0.98 [0.85-1.12],0.7279309849351093
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18492,403,0.99 [0.87-1.12],0.8901169988582208
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19392,2101,0.98 [0.93-1.04],0.4871780620399571
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18527,438,1.01 [0.89-1.13],0.915612133809818
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Later onset COPD,19170,1254,0.98 [0.91-1.06],0.6286194257223309
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19605,378,0.98 [0.86-1.12],0.819267194627261
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Nasal polyp,18598,85,0.96 [0.72-1.27],0.7752315353396992
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19379,1051,0.98 [0.90-1.06],0.6108329943121844
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19375,2227,1.02 [0.97-1.08],0.4154768749854544
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19159,646,0.96 [0.86-1.06],0.4381964066288086
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other pleural conditions,17203,55,0.62 [0.37-1.04],0.0686996937104562
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19508,513,0.99 [0.88-1.11],0.8369958216291145
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19507,1434,1.04 [0.97-1.10],0.2783078337866289
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pleural effusion,18251,1103,0.99 [0.92-1.07],0.8490301307037318
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pleural plaque,17369,221,1.02 [0.86-1.20],0.8540381937118455
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19155,1864,0.97 [0.91-1.03],0.3194189013767797
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19512,285,1.00 [0.86-1.16],0.9720011623189184
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pneumothorax,17296,148,1.02 [0.83-1.25],0.8789837865228171
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pollen allergy,19612,172,1.04 [0.87-1.25],0.6743528774918575
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19069,74,0.96 [0.70-1.30],0.7725884207667475
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12150,59,0.82 [0.55-1.23],0.3384313628908806
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19363,1035,0.98 [0.91-1.07],0.6914914255665914
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18716,203,1.03 [0.86-1.22],0.764649654165632
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Viral pneumonia,17532,241,1.00 [0.84-1.17],0.9537868221477088
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19192,193,1.01 [0.85-1.21],0.8792428837838119
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6329,101,0.92 [0.69-1.23],0.5722931270430187
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12552,52,0.73 [0.46-1.18],0.2029657328509999
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute appendicitis,19519,108,0.94 [0.72-1.22],0.6294586336482275
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute gastritis,13718,83,1.02 [0.78-1.35],0.8790766186363065
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,17933,164,0.89 [0.71-1.11],0.3110533875269805
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Acute peritonitis,19222,91,1.19 [0.96-1.47],0.1044157351651783
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18800,49,1.17 [0.86-1.58],0.311018143470507
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,14051,416,1.01 [0.89-1.15],0.8542393534947597
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17890,121,1.10 [0.90-1.35],0.3680355968122705
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19277,121,1.09 [0.89-1.34],0.3995510480153245
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Cholecystitis,17948,179,1.12 [0.95-1.32],0.1925329408602804
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Cholelithiasis,18655,886,1.05 [0.97-1.14],0.2114205804385223
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Chronic gastritis,13930,295,1.11 [0.97-1.26],0.141441856696709
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17815,46,1.18 [0.87-1.59],0.2884024603860772
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19505,109,1.13 [0.92-1.39],0.2489198057684165
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Coeliac disease,18179,104,1.08 [0.86-1.35],0.4966093516174078
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Collagenous colitis,18154,88,1.01 [0.78-1.32],0.9399709017395091
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19523,141,1.00 [0.81-1.24],0.9633374053380318
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Constipation,19382,1731,0.96 [0.90-1.02],0.1799750566868022
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Crohn disease,18132,66,0.95 [0.69-1.32],0.7642821962321802
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19331,52,0.99 [0.70-1.41],0.9727587340660068
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18127,61,0.94 [0.67-1.32],0.7217206187540822
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Dental caries,19097,156,0.95 [0.76-1.17],0.6088237346140688
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16994,2148,1.02 [0.96-1.07],0.5511001146076024
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of appendix,19544,133,0.92 [0.73-1.17],0.5129897070103275
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of liver,19524,773,0.97 [0.88-1.06],0.4647607736211682
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17482,3847,1.04 [1.00-1.08],0.0644866298502863
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19338,397,1.05 [0.93-1.18],0.4169837659082624
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19549,418,1.00 [0.88-1.13],0.9620122047128472
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19016,75,1.17 [0.92-1.48],0.1946650527384973
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18914,44,0.79 [0.48-1.28],0.3308380776931616
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19353,1278,1.01 [0.94-1.08],0.8712338718143471
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diseases of tongue,18925,77,1.09 [0.84-1.41],0.5196074842954457
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19041,1272,1.04 [0.97-1.11],0.2963884208309939
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15697,3197,1.01 [0.96-1.05],0.7303253141621127
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,13837,202,0.90 [0.74-1.11],0.3262824209731905
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19532,161,0.87 [0.69-1.09],0.2294157399633869
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19594,18,0.87 [0.43-1.75],0.6982312881291787
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18878,127,1.11 [0.92-1.35],0.2797507539393847
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12595,95,1.09 [0.86-1.38],0.4787196040413569
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,14108,473,1.06 [0.95-1.18],0.3283382183718587
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastric ulcer,13992,357,1.04 [0.91-1.19],0.5438944905321906
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15858,2223,1.06 [1.00-1.11],0.0381378587916565
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14179,544,1.00 [0.90-1.12],0.987468968471046
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14254,6944,1.03 [1.00-1.06],0.0395894641012384
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,GI-bleeding,19122,1047,1.00 [0.92-1.08],0.9341258371876996
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18985,44,0.99 [0.67-1.45],0.9399043561683428
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13346,1010,1.06 [0.98-1.14],0.1462207047126263
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18809,58,1.07 [0.79-1.46],0.6624948921198885
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Hernia,17890,3044,1.00 [0.95-1.04],0.8963587721236269
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Impacted teeth,19596,17,0.89 [0.44-1.80],0.7480246503107153
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Impaction of intestines,12565,65,0.91 [0.65-1.28],0.5814214398520554
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Inguinal hernia,15760,914,1.00 [0.92-1.09],0.9628566624181174
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14945,99,0.88 [0.66-1.18],0.3989292271841248
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12595,95,1.08 [0.85-1.37],0.5135588212267447
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18198,123,1.01 [0.81-1.27],0.9065350117514316
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12928,428,0.97 [0.86-1.10],0.65194758305844
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19601,278,0.81 [0.67-0.97],0.0249238900105056
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18721,655,1.02 [0.93-1.12],0.7101839827920402
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18985,919,0.99 [0.91-1.08],0.892282886910807
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13813,178,1.06 [0.88-1.27],0.5538596356373554
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oesophagitis,14221,586,1.03 [0.93-1.15],0.5113016070824998
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19573,113,0.97 [0.76-1.24],0.7930019714842972
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14916,70,1.19 [0.94-1.50],0.1453798222495647
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13658,1158,0.95 [0.87-1.02],0.1630556249302267
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18065,296,1.01 [0.87-1.17],0.8878740717521048
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17892,123,1.04 [0.84-1.29],0.7294560584905376
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14135,1635,1.02 [0.96-1.08],0.5365298516218983
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,17681,5181,1.00 [0.96-1.03],0.8602996327989932
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18898,181,1.06 [0.89-1.26],0.5155412023759406
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19388,637,0.93 [0.83-1.04],0.1859134150355571
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14271,636,1.04 [0.94-1.14],0.4559266026826805
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17938,169,0.94 [0.76-1.15],0.541237195424003
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19485,354,1.00 [0.88-1.15],0.955565298616666
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14551,916,1.03 [0.95-1.12],0.5317449617585253
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19134,1059,1.00 [0.92-1.08],0.9012530401987524
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19088,147,1.06 [0.88-1.29],0.5391895617412104
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14269,1769,0.96 [0.90-1.02],0.1588478728451559
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15465,1830,1.01 [0.96-1.08],0.6476523903576701
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18849,98,1.14 [0.91-1.41],0.2510389008972913
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18880,814,0.98 [0.90-1.08],0.7314906617269608
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12869,369,1.04 [0.92-1.18],0.5069629295547446
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19591,22,0.86 [0.46-1.63],0.6518329615836763
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13017,517,1.06 [0.95-1.17],0.287025406642717
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18215,140,1.02 [0.83-1.26],0.8308141043641396
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19610,44,1.01 [0.69-1.46],0.9674827677633798
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18933,84,1.01 [0.77-1.32],0.9468872191734924
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Toxic colitis,18139,73,1.01 [0.76-1.35],0.9206544445249906
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13929,294,1.02 [0.88-1.18],0.7872906185574586
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18206,140,0.93 [0.73-1.17],0.5178916899451471
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18179,113,0.97 [0.76-1.24],0.8320154471691839
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15061,215,0.93 [0.77-1.11],0.4100687642801248
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12705,205,0.99 [0.83-1.19],0.9437669157304496
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Ventral hernia,15075,229,0.97 [0.82-1.15],0.7498185153680577
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XI Diseases of the digestive system,Volvulus,12577,77,1.16 [0.91-1.47],0.2277468318690783
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19532,352,1.04 [0.92-1.18],0.5318394942055231
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19315,62,0.94 [0.67-1.33],0.7214863828444177
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17507,142,1.02 [0.83-1.25],0.8571614890858955
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19093,691,1.01 [0.92-1.11],0.7970022121592759
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18520,118,1.05 [0.84-1.31],0.6681976331097241
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17858,493,0.99 [0.88-1.11],0.8256499396206747
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19323,262,1.00 [0.86-1.17],0.981375441232483
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19527,466,1.00 [0.89-1.13],0.963512594731427
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19104,43,1.00 [0.69-1.47],0.9864645299090468
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18276,3134,1.01 [0.96-1.05],0.7218582053832717
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19262,364,1.00 [0.88-1.14],0.99565460126676
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19148,250,1.00 [0.85-1.17],0.98943207638071
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19295,893,1.02 [0.94-1.10],0.6893436686883816
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19605,49,0.82 [0.53-1.28],0.3853762137819123
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17421,56,1.18 [0.89-1.55],0.2433658002256861
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18952,54,0.97 [0.68-1.38],0.8669188976726572
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19311,250,1.00 [0.85-1.17],0.992006200837758
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17877,512,1.07 [0.97-1.19],0.1649813694765769
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17443,78,1.12 [0.87-1.43],0.371815350511042
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19550,71,0.92 [0.67-1.28],0.6318492413180526
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18580,178,1.09 [0.92-1.30],0.3002127438471411
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19448,195,1.05 [0.88-1.24],0.5904572527995624
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19137,76,0.84 [0.60-1.19],0.3279040324441282
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17428,63,1.06 [0.79-1.42],0.7111850662432966
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19105,1740,1.01 [0.95-1.07],0.7949295627211342
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17915,550,1.06 [0.96-1.17],0.2717538359704965
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17446,81,1.10 [0.86-1.41],0.4590129526952912
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19544,291,0.99 [0.85-1.15],0.8594615494169804
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19127,66,1.13 [0.87-1.47],0.3550665323156745
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19494,241,1.02 [0.87-1.19],0.8396645601400553
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19561,381,1.02 [0.90-1.15],0.8110920419748464
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17471,106,1.09 [0.87-1.35],0.4630594938065683
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17645,280,0.93 [0.79-1.09],0.3799779888096455
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19549,369,1.02 [0.90-1.16],0.7675413300099749
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17631,266,1.04 [0.89-1.20],0.638082216693554
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19598,119,0.92 [0.71-1.18],0.4994766298108787
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16385,69,1.15 [0.88-1.49],0.2995755881676081
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17316,5417,1.01 [0.97-1.04],0.6782943161332995
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16137,4238,1.01 [0.97-1.05],0.6408372640119127
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16361,45,1.11 [0.79-1.55],0.541614556874749
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16349,118,1.02 [0.81-1.27],0.8893201805777496
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16384,153,0.90 [0.71-1.13],0.3503545689478229
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19407,51,0.98 [0.69-1.41],0.9289947047895069
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16355,124,1.12 [0.92-1.36],0.260571860511847
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13152,1253,1.01 [0.94-1.08],0.8262374540859573
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19441,211,0.91 [0.75-1.10],0.3439269190029195
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16698,467,0.94 [0.83-1.07],0.3425603234620916
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15900,6771,1.01 [0.98-1.04],0.3830217974676229
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17517,106,0.86 [0.64-1.14],0.2855235897555234
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16466,150,1.14 [0.96-1.36],0.1378108832327422
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16743,427,1.13 [1.02-1.26],0.0208723720521836
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18820,2589,0.97 [0.92-1.02],0.1988061516952682
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16578,262,0.90 [0.76-1.08],0.258322210350166
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16437,121,0.95 [0.75-1.21],0.7033100516409454
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16414,98,1.09 [0.87-1.37],0.4613527581802242
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18960,87,0.85 [0.62-1.17],0.3136274660868829
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13606,1707,1.01 [0.95-1.07],0.702255714541397
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12535,636,1.00 [0.90-1.10],0.9362636257143035
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19537,630,0.98 [0.89-1.09],0.7345896563873
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11958,59,0.74 [0.48-1.15],0.1823394468285153
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12159,260,1.17 [1.03-1.33],0.0177512398965189
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16539,223,1.13 [0.98-1.31],0.0902873040147594
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12315,416,0.89 [0.78-1.03],0.1166543248790973
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16296,65,0.92 [0.66-1.30],0.6496877649419077
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16791,560,0.98 [0.88-1.09],0.6557994141965029
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16481,250,1.02 [0.87-1.19],0.8102000983840468
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12288,389,0.88 [0.76-1.02],0.0805288961083487
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16377,61,0.93 [0.65-1.32],0.6655250904188798
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16362,46,1.07 [0.76-1.50],0.7105479069234292
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17477,66,0.77 [0.52-1.15],0.2091728885700745
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19260,1849,0.96 [0.90-1.02],0.1434770242853804
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18714,1303,0.96 [0.89-1.03],0.223064196013098
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19481,459,0.99 [0.88-1.12],0.9005128639431138
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14541,2642,1.03 [0.99-1.08],0.1562055439657284
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11937,38,0.78 [0.46-1.33],0.3621099201873239
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16401,85,0.88 [0.65-1.21],0.4400481852602952
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11962,63,1.09 [0.82-1.45],0.5665043374072991
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12015,116,1.22 [1.01-1.46],0.0353551452881145
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17612,201,1.00 [0.84-1.19],0.990107320818564
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17816,405,0.93 [0.81-1.06],0.2952389545432305
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19605,88,0.95 [0.72-1.26],0.7474194964709489
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17863,1632,0.96 [0.90-1.03],0.2279538997831169
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16375,59,0.70 [0.44-1.11],0.1325904854360249
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12026,127,1.03 [0.83-1.27],0.8212030543992642
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16886,655,1.02 [0.92-1.12],0.7416110716403376
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13728,1829,1.00 [0.94-1.06],0.9072838340677792
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18981,108,0.88 [0.67-1.16],0.3529940290117017
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19614,59,0.91 [0.63-1.31],0.6083280943091854
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16383,67,0.93 [0.67-1.30],0.6853719593827419
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17435,1119,0.98 [0.91-1.06],0.6744442753859117
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16403,87,1.14 [0.91-1.43],0.2563062681921268
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13645,1746,1.00 [0.94-1.07],0.9041572681825614
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17511,100,1.02 [0.80-1.30],0.8495713948218991
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16342,26,1.11 [0.72-1.71],0.6270301553692061
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16394,163,1.00 [0.82-1.21],0.9710885104345922
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16883,567,1.06 [0.96-1.17],0.274011333144886
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19295,422,0.90 [0.78-1.03],0.1226741981032922
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16768,537,0.89 [0.78-1.00],0.056181246349295
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19493,455,0.99 [0.88-1.12],0.9109340861784117
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19599,56,0.59 [0.34-1.00],0.051094277473104
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16453,137,1.13 [0.94-1.36],0.1982498816794257
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15290,717,1.03 [0.94-1.13],0.4966530636908086
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16847,531,0.97 [0.87-1.09],0.5897296311932514
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16551,235,0.86 [0.71-1.05],0.1357487283640573
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11962,63,1.23 [0.96-1.58],0.0965142992277095
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14515,2616,1.01 [0.96-1.06],0.8338683504462379
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12598,699,1.07 [0.98-1.17],0.118810600567403
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19185,312,0.83 [0.70-0.98],0.0320335783011844
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19578,61,1.01 [0.73-1.38],0.9657253262899012
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17368,57,1.07 [0.79-1.46],0.652773463710197
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11959,60,0.91 [0.64-1.31],0.6217933032261047
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16322,91,0.88 [0.66-1.19],0.4102040968982751
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12364,465,1.00 [0.89-1.13],0.9763208645616148
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16600,284,1.03 [0.89-1.18],0.7272736118655148
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16466,235,1.00 [0.85-1.17],0.9588013571359494
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16449,218,0.87 [0.72-1.06],0.1725392298121401
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13821,59,1.03 [0.75-1.42],0.8563833425801456
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19603,60,0.68 [0.42-1.08],0.1047305089743882
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16785,469,1.10 [0.99-1.22],0.0639211030415378
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],18961,88,1.02 [0.78-1.32],0.9086781343151844
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18519,2203,1.02 [0.97-1.08],0.3537070167457781
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16440,124,0.89 [0.68-1.14],0.3530117850949733
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16797,566,1.00 [0.90-1.11],0.9535250867849494
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18443,222,1.03 [0.88-1.21],0.7178050100013158
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16427,196,1.01 [0.85-1.21],0.8895679702417972
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17855,1624,1.00 [0.94-1.06],0.9575422468592518
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17296,1065,0.98 [0.91-1.06],0.6531934971338962
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16364,48,0.82 [0.52-1.28],0.3793882586961443
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18983,110,1.20 [0.99-1.45],0.0687985340531269
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16460,144,1.09 [0.91-1.32],0.354434386535855
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16395,79,0.96 [0.72-1.29],0.8050067609348153
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11960,61,0.90 [0.62-1.30],0.5605058203460802
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18503,1790,1.02 [0.96-1.08],0.5543419520435665
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7909,22,1.39 [0.97-1.98],0.0719937911917709
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10038,28,0.98 [0.61-1.59],0.9487188630830664
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19350,260,0.91 [0.77-1.08],0.2825498888136908
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19178,88,0.76 [0.53-1.08],0.1248312687051436
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18429,1716,0.99 [0.93-1.05],0.778871621120296
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19439,87,0.94 [0.71-1.25],0.6894723660300234
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19402,330,0.99 [0.86-1.14],0.9146089542193144
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Cystitis,16472,255,0.95 [0.80-1.12],0.510182617944521
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Dialysis,16782,69,0.72 [0.47-1.09],0.1222642689148857
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8595,1774,0.96 [0.90-1.02],0.1576270150402967
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10118,108,1.09 [0.88-1.36],0.4380952525341148
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,7921,34,1.34 [0.99-1.81],0.0575870629543447
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8369,482,1.10 [0.99-1.22],0.0680138092451601
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16209,5186,1.00 [0.97-1.04],0.9902419544024388
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19420,68,0.81 [0.55-1.18],0.2755708472681657
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,6923,102,1.01 [0.79-1.28],0.9412289911884096
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16737,272,1.01 [0.87-1.18],0.8602654448185545
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8333,1512,0.96 [0.89-1.02],0.1995614708716787
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10174,137,0.92 [0.73-1.17],0.502189652378488
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6924,103,0.97 [0.75-1.25],0.8007853506691771
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16287,70,0.82 [0.57-1.18],0.291400096591717
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8756,869,1.05 [0.96-1.13],0.2759439816333641
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6871,50,1.19 [0.89-1.58],0.2448205552384892
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7920,33,1.27 [0.91-1.78],0.1539971744821417
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19615,75,0.97 [0.72-1.31],0.8369299252800106
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19610,74,1.10 [0.84-1.42],0.4909177935716834
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18613,2396,0.99 [0.94-1.04],0.6235426188393554
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17004,787,0.91 [0.83-1.01],0.06624473051812
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10055,45,1.07 [0.76-1.52],0.6960243852736003
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19560,488,1.00 [0.90-1.12],0.9401446400498784
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6942,121,0.96 [0.76-1.21],0.7309838893685446
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6958,137,0.78 [0.59-1.02],0.0719508489887953
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6944,123,0.89 [0.69-1.14],0.3612682008423601
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19590,69,1.25 [1.00-1.57],0.0520649217096312
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18091,1874,1.02 [0.96-1.08],0.5797922356174214
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10108,71,1.02 [0.76-1.36],0.8899323021865361
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7950,63,0.60 [0.36-0.98],0.0421269395890707
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8018,131,0.91 [0.71-1.17],0.4616444571503243
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7935,48,0.81 [0.52-1.27],0.3541906812658006
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7972,85,1.18 [0.94-1.47],0.1528376353956518
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16787,322,1.00 [0.87-1.15],0.9759822921703764
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19226,154,1.08 [0.90-1.30],0.3916872193016478
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7993,106,1.08 [0.86-1.35],0.5257614773840874
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7909,22,1.24 [0.83-1.86],0.2881092428796433
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8070,183,1.08 [0.91-1.28],0.3872364458778639
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7967,80,0.92 [0.67-1.25],0.5962466453017674
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8061,174,1.12 [0.95-1.33],0.1637919365369942
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19399,47,0.97 [0.67-1.42],0.8896196649324649
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6946,125,1.02 [0.82-1.27],0.8491467847171161
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19419,2954,1.00 [0.95-1.05],0.9659694236523196
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16542,77,0.75 [0.51-1.10],0.1407048771746331
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16851,138,1.04 [0.85-1.28],0.7085890748672329
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19120,30,0.77 [0.43-1.40],0.3953743410028214
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16442,225,0.99 [0.83-1.17],0.8877696367997338
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19423,333,0.90 [0.78-1.05],0.1943400216261452
KCNH2,Potassium voltage-gated channel subfamily H member 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7920,33,0.91 [0.55-1.49],0.6951457980957516
